BCR and acute lymphoblastic leukemia: Our study aimed to analyze the the ABL1 KD mutations in 97 consecutive newly‐diagnosed adults with BCR::ABL1‐positive ALL before therapy, in cytogenetic complete remission and at relapse with next generation sequencing (NGS).